GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Akerna Corp (NAS:KERN) » Definitions » Debt-to-EBITDA

Akerna (Akerna) Debt-to-EBITDA : -1.42 (As of Sep. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Akerna Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Akerna's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was $7.73 Mil. Akerna's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was $0.85 Mil. Akerna's annualized EBITDA for the quarter that ended in Sep. 2023 was $-6.03 Mil. Akerna's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2023 was -1.42.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Akerna's Debt-to-EBITDA or its related term are showing as below:

KERN' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -1.02   Med: -0.66   Max: -0.18
Current: -0.18

During the past 6 years, the highest Debt-to-EBITDA Ratio of Akerna was -0.18. The lowest was -1.02. And the median was -0.66.

KERN's Debt-to-EBITDA is not ranked
in the Healthcare Providers & Services industry.
Industry Median: 2.565 vs KERN: -0.18

Akerna Debt-to-EBITDA Historical Data

The historical data trend for Akerna's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akerna Debt-to-EBITDA Chart

Akerna Annual Data
Trend Dec17 Dec18 Jun19 Jun20 Dec21 Dec22
Debt-to-EBITDA
Get a 7-Day Free Trial - - -1.02 -0.66 -0.29

Akerna Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.28 -0.08 -1.31 -1.73 -1.42

Competitive Comparison of Akerna's Debt-to-EBITDA

For the Health Information Services subindustry, Akerna's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Akerna's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Akerna's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Akerna's Debt-to-EBITDA falls into.



Akerna Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Akerna's Debt-to-EBITDA for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(13.2 + 1.407) / -50.653
=-0.29

Akerna's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(7.733 + 0.85) / -6.032
=-1.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Sep. 2023) EBITDA data.


Akerna  (NAS:KERN) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Akerna Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Akerna's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Akerna (Akerna) Business Description

Traded in Other Exchanges
N/A
Address
1550 Larimer Street, No 246, Denver, CO, USA, 80202
Akerna Corp is a United States-based company provider of enterprise software solutions within the cannabis industry. It offers MJ Platform and Leaf Data Systems which are platforms that provide clients and government entities with a central data management system for tracking regulated cannabis products from seed to product to shelf to customers through the supply chain. It has two sources of revenue software and consulting services, and the majority of the revenue comes from commercial software platforms.
Executives
Mj Bridge Co., Inc. 10 percent owner 16192 COASTAL HIGHWAY, LEWES DE 19958
Barry Fishman director C/O AKERNA CORP., 1550 LARIMER STREET, SUITE 246, DENVER CO 80202
Matthew Ryan Kane director AKERNA CORP., 1601 ARAPAHOE ST., DENVER CO 80202
Thompson Cecil Ray Jr officer: Chief Operating Officer 1630 WELTON ST, SUITE 400, DENVER CO 80201
David R Mccullough officer: Chief Technology Officer C/O AKERNA CORP., 1630 WELTON STREET - 4TH FLOOR, DENVER CO 80202
Jessica Billingsley director, 10 percent owner, officer: Chief Executive Officer AKERNA CORP., 1601 ARAPAHOE ST., DENVER CO 80202
Amy A. Poinsett Revocable Living Trust 10 percent owner 601 16TH STREET, SUITE C-420, GOLDEN CO 80403
Fowle John Michael Jr officer: Chief Financial Officer AKERNA CORP., 1601 ARAPAHOE ST., DENVER CO 80202
Tahira Rehmatullah director C/O AKERNA CORP., 1601 ARAPAHOE STREET, DENVER CO 32836
Ashesh C Shah director AKERNA CORP., 1601 ARAPAHOE ST., DENVER CO 80202
Nina Simosko officer: Chief Revenue Officer AKERNA CORP., 1601 ARAPAHOE ST., DENVER CO 80202
Scott Sozio director BAY HARBOUR MANAGEMENT, 885 THIRD AVENUE, 34TH FLOOR, NEW YORK NY 10022
Jessica Billingsley Living Trust 10 percent owner 1601 ARAPAHOE STREET, DENVER CO 80202
Amy A. Poinsett 10 percent owner 601 16TH STREET, SUITE C-420, GOLDEN CO 80401
Mtech Sponsor Llc 10 percent owner 10124 FOXHURST CT, ORLANDO FL 32836